Characteristics of the Ontario Neurodegenerative Disease Research Initiative cohort.
Kelly M SunderlandDerek BeatonStephen R ArnottPeter KleinstiverDonna KwanJane M Lawrence-DewarJoel RamirezBrian TanRobert BarthaSandra E BlackMichael BorrieDonald C BrienLeanne K CasaubonBrian C CoeBenjamin CornishAllison Ann DilliottDariush DowlatshahiElizabeth FingerCorinne E FischerAndrew FrankJulia FraserMorris FreedmanBarry GreenbergDavid A GrimesAyman HassanWendy HatchRobert A HegeleChristopher HudsonMandar JogSanjeev KumarAnthony LangBrian LevineWendy LouJennifer L MandziaConnie MarrasWilliam McIlroyManuel Montero-OdassoDavid G MunozDouglas P MunozJoseph B OrangeDavid S ParkStephen H PasternakFrederico Pieruccini-FariaTarek K RajjiAngela C RobertsJohn F RobinsonEkaterina A RogaevaDemetrios J SahlasGustavo SaposnikChristopher J M ScottDallas SeitzChristen ShoesmithThomas D L SteevesChristopher J KleinStephen S StrotherRichard H SwartzSean SymonsDavid F Tang-WaiMaria Carmela TartagliaAngela K TroyerJohn TurnbullLorne ZinmanPaula M McLaughlinMario MasellisMalcolm A Binnsnull nullPublished in: Alzheimer's & dementia : the journal of the Alzheimer's Association (2022)
Data will be shared with the global scientific community. Within-disease and disease-agnostic approaches are expected to identify markers of severity, progression, and therapy targets. Sampling characteristics also provide guidance for future study design.